| Literature DB >> 17875071 |
Manabu Suzuki1, Satoshi Hirano, Hideyuki Ito, Daisuke Matsubara, Kazuo Kubota, Yuichiro Takeda, Haruhito Sugiyama, Nobuyuki Kobayashi, Koichiro Kudo.
Abstract
Low dose weekly administration of methotrexate has been thought to be effective for both rheumatoid arthritis (RA) and psoriasis. However, there is a possibility that methotrexate therapy may be oncogenic. This report presents a case of pulmonary lymphoma developed during long-term methotrexate therapy for psoriasis. Physicians should be aware that Epstein-Barr virus-associated lymphoproliferative disorders that occur during treatment with methotrexate are not specific to patients with RA.Entities:
Mesh：
Substances：
Year: 2007 PMID： 17875071 DOI： 10.1111/j.1440-1843.2007.01139.x
Source DB: PubMed Journal: Respirology ISSN： 1323-7799 Impact factor: 6.424